From an open field to a worldclass drug product manufacturing campus – See the latest progress update on our Middletown, DE, facility.
Phase I of this 190-acre facility will be operational by the end of 2026, offering oral solid dosage manufacturing, full analytical and microbiology lab support, and clinical packaging, labeling, and distribution.
In 2027, we’ll expand even further with sterile fill/finish capabilities to support vials, cartridges, and pre-filled syringes.
Watch the latest construction progress and see how WuXi STA is building with purpose — we move fast so our clients can move forward.
